Total planned funding: $395,843,041
Clear active filters
FHI 360
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Zambia | $68,243,216 |
Nigeria | $63,049,951 |
Mozambique | $58,672,177 |
Tanzania | $28,163,822 |
Kenya | $21,958,027 |
Vietnam | $17,830,517 |
Rwanda | $16,736,398 |
South Africa | $16,244,904 |
Burundi | $13,917,972 |
Haiti | $11,920,043 |
Cambodia | $9,950,000 |
Indonesia | $8,619,829 |
India | $7,388,825 |
Côte d'Ivoire | $6,160,896 |
South Sudan | $5,704,062 |
Zimbabwe | $5,558,697 |
Ethiopia | $4,683,136 |
Uganda | $4,012,161 |
Asia Regional Program | $3,727,521 |
Papua New Guinea | $3,708,980 |
Malawi | $2,523,759 |
Caribbean Region | $2,519,565 |
China | $2,350,000 |
Central America Region | $2,283,457 |
Angola | $2,222,878 |
Botswana | $1,900,000 |
Dominican Republic | $1,418,747 |
Democratic Republic of the Congo | $1,300,000 |
Ghana | $1,290,000 |
Eswatini | $594,902 |
Thailand | $478,599 |
Cameroon | $360,000 |
Central Asia Region | $350,000 |
Organizational Types
NGO | $380,521,604 |
Implementing Agency | $15,321,437 |
Program Areas
Prevention | $115,894,029 |
Care | $102,230,733 |
Treatment | $96,958,473 |
Testing | $43,345,749 |
Governance and Systems | $37,414,057 |
Budget Codes
HTXS: Treatment: Adult Treatment | $85,160,463 |
HVOP: Sexual Prevention: Other Sexual Prevention | $55,999,971 |
HVCT: Testing: HIV Testing and Counseling | $43,345,749 |
HKID: Care: Orphans and Vulnerable Children | $42,450,766 |
HBHC: Care: Adult Care and Support | $42,206,866 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $28,508,600 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $21,240,584 |
HVSI: Strategic Information | $14,453,840 |
HLAB: Laboratory Infrastructure | $14,272,334 |
HVTB: Care: TB/HIV | $11,561,886 |
OHSS: Health Systems Strengthening | $8,687,883 |
PDTX: Treatment: Pediatric Treatment | $8,374,726 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $7,302,515 |
PDCS: Care: Pediatric Care and Support | $6,011,215 |
HTXD: Treatment: ARV Drugs | $3,423,284 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $2,282,359 |
HMIN: Biomedical Prevention: Injection Safety | $380,000 |
HMBL: Biomedical Prevention: Blood Safety | $180,000 |
Top Partner Programs
FHI 360:
$395,843,041
View countries